Characteristics of Pain Assessed with Visual Analog Scale and Questionnaire in Burning Mouth Syndrome Patients: A Pilot Study

Aims: To test the validity of the use of the Douleur Neuropathique en 4 Questions (DN4) questionnaire for burning mouth syndrome (BMS) patients, and to differentiate patients by measuring the time course of the pain in BMS patients over a period of 7 days with a visual analog scale (VAS). Methods: Patients completed the DN4 questionnaire and a VAS every hour for 7 days. The data were expressed as mean ± SEM. Correlations were searched using the Spearman correlation test with a significance level at P < .05. Results: Data were fully analyzed for the 22 patients (21 females, 1 male, mean [± SEM] age 62.7 ± 2.3 years) for the DN4 and 17 patients for the VAS. DN4 scores ranged from 2 to 7 (mean score: 3.9 ± 0.3), and 59% of the patients had a DN4 score ≥ 4. Burning was found in all the patients, followed by pricking pain (pins and needles) and allodynia (pain on brushing) (both 68%), tingling (45%), numbness (32%), itching (27%), and electrical discharges (23%). Monitoring the hourly time-course of the pain led to the identification of two groups with intermittent or constant pain. In the latter, averaging the VAS for 7 days enabled plotting a curve, the slope of which could be calculated. The range of the slopes was 0.00 to 0.59, and a regular increase of pain during the day was seen for the majority of the patients. Conclusion: The findings support the use of DN4 as a tool for screening BMS and reinforce the view that BMS is a clinical manifestation of a neuropathic disease. The methodology of this study can be used for a better description of the patients and the identification of subgroups.

burning mouth syndrome; DN4; pain; visual analog scale

1. Woda a, Tubert-Jeannin S, Bouhassira D, et al. Towards a new taxonomy of idiopathic orofacial pain. Pain 2005; 116:396–406.

2. Bergdahl M, Bergdahl J. Burning mouth syndrome: Prevalence and associated factors. J Oral Pathol 1999;28:350–354.

3. Basker rM, Sturdee DW, Davenport Jc. Patients with burning mouths. a clinical investigation of causative factors, including the climacteric and diabetes. Br Dent J 1978;145:9–16.

4. Grushka M. clinical features of burning mouth syndrome. Oral Surg Oral Med Oral Pathol 1987;63:30–36.

5. Grushka M, Epstein JB, Gorsky M,. Burning mouth syndrome. am fam Phys 2002;65:615–620.

6. Woda a, Dao T, Gremeau-richard c. Steroid dysregulation and stomatodynia (burning mouth syndrome). J Orofac Pain 2009;23:202–210.

7. forssell H, Jääskeläinen S, Tenovuo O, Hinkka S. Sensory dysfunction in burning mouth syndrome. Pain 2002;99: 41–47.

8. Grushka M, Sessle BJ, Howley TP. Psychophysical assessment of tactile, pain and thermal sensory functions in burning mouth syndrome. Pain 1987;28:169–184.

9. Jääskeläinen SK, forssell H , Tenovuo O. abnormalities of the blink reflex in burning mouth syndrome. Pain 1997;73: 455–460.

10. Gao S, Wang Y, Wang Z. assessment of trigeminal somatosensory evoked potentials in burning mouth syndrome. chin J Dent res 2000;3:40–46.

11. Lauria G, Majorana a, Borgna M, et al. Trigeminal small-fiber sensory neuropathy causes burning mouth syndrome. Pain 2005;115:332–337.

12. Yilmaz Z, renton T, Yiangou Y, et al. Burning mouth syndrome as a trigeminal small fibre neuropathy: increased heat and capsaicin receptor TrPV1 in nerve fibres correlates with pain score. J clin neurosci 2007;14:864–871.

13. Lauria G. Small fibre neuropathies. curr Opin neurol 2005; 18:591–597.

14. formaker BK, Mott aE, frank ME. The effects of topical anesthesia on oral burning in burning mouth syndrome. ann nY acad Sci 1998;855:776–780.

15. Grémeau-richard c, Dubray c, aublet-cuvelier B, Ughetto S, Woda a. Effect of lingual nerve block on burning mouth syndrome (stomatodynia): a randomized crossover trial. Pain 2010;149:27–32.

16. Gremeau-richard c, Woda a, navez ML, et al. Topical clonazepam in stomatodynia: a randomised placebo- controlled study. Pain 2004;108:51–57.

17. Hagelberg n, forssell H, rinne JO, et al. Striatal dopamine D1 and D2 receptors in burning mouth syndrome. Pain 2003; 101:149–154.

18. Jääskeläinen SK, rinne JO, forssell H, et al. role of the dopaminergic system in chronic pain—a fluorodopa-PET study. Pain 2001;90:257–260.

19. albuquerque rJ, de Leeuw r, carlson cr, Okeson JP, Miller cS, andersen aH. cerebral activation during thermal stimulation of patients who have burning mouth disorder: an fMri study. Pain 2006;122:223–234.

20. Jääskeläinen SK. Pathophysiology of primary burning mouth syndrome. clin neurophys 2012;123:71–77.

21. Buchanan Ja, Zakrzewska JM. Burning mouth syndrome. clinical Evid (Online) 2010 Jul 19;2010. pii:1301.

22. nagashima W, Kimura H, ito M, et al. Effectiveness of duloxetine for the treatment of chronic nonorganic orofacial pain. clin neuropharmacol 2012;35:273–277.

23. Scala a, checchi L, Montevecchi M, Marini i, Giamberardino Ma. Update on burning mouth syndrome: Overview and patient management. crit rev Oral Biol Med 2003;14: 275–291.

24. Bouhassira D, attal n, alchaar H, et al. comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (Dn4). Pain 2005;114:29–36.

25. Bergdahl J, anneroth G. Burning mouth syndrome: Literature review and model for research and management. J Oral Pathol 1993;22:433–438.

26. Bruynzeel DP, andersen KE, camarasa JG, et al. The European standard series. European Environmental and contact Dermatitis research Group (EEcDrG). contact Dermatitis 1995;33:145–148.

27. Lamey PJ, Lamb aB. Prospective study of aetiological factors in burning mouth syndrome. Br Med J (clin res Ed) 1988;296:1243–1246.

28. Danhauer Sc, Miller cS, rhodus nL, carlson cr. impact of criteria-based diagnosis of burning mouth syndrome on treatment outcome. J Orofac Pain 2002;16:305–311.

29. Hakeberg M, Hallberg Lr-M, Berggren U. Burning mouth syndrome: Experiences from the perspective of female patients. Eur J Oral Sci 2003;111:305–311.

30. Silvestre fJ, Silvestre-rangil J, Tamarit-Santafé c, Bautista D. application of a capsaicin rinse in the treatment of burning mouth syndrome. Med Oral Patol Oral cir Bucal 2012; 17:e1–e4.

31. de Tommaso M, Lavolpe V, Di Venere D, et al. a case of unilateral burning mouth syndrome of neuropathic origin. Headache 2011;51:441–444.

32. Svensson P, Drangsholt M, Pfau DB, List T. neurosensory testing of orofacial pain in the dental clinic. J am Dent assoc 2012;143:e37–e39.

33. Pigg M, Baad-Hansen L, Svensson P, Drangsholt M, List T. reliability of intraoral quantitative sensory testing (QST). Pain 2010;148:220–226.

34. Svensson P, Baad-Hansen L, Pigg M, et al. Special interest Group of Oro-facial Pain. Guidelines and recommendations for assessment of somatosensory function in oro-facial pain conditions—a taskforce report. J Oral rehabil 2011; 38:366–394.

35. ito M, Kurita K, ito T, arao M. Pain threshold and pain recovery after experimental stimulation in patients with burning mouth syndrome. Psychiatry clin neurosci 2002;56: 161–168.

36. Baum c, Huber c, Schneider r, Lautenbacher S. Prediction of experimental pain sensitivity by attention to pain-related stimuli in healthy individuals. Percept Mot Skills 2011; 112:926–946.

37. Jensen MP, Turner Ja, romano JM, fisher LD. comparative reliability and validity of chronic pain intensity measures. Pain 1999;83:157–162.

38. Williamson a, Hoggart B. Pain: a review of three commonly used pain rating scales. J clin nurs 2005;14:798–804.

39. forssell H, Teerijoki-Oksa T, Kotiranta U, et al. Pain and pain behavior in burning mouth syndrome: a pain diary study. J Orofac Pain 2012,26:117–125.

40. Lamey PJ, Lewis MaO. Oral medicine in practice: Burning mouth syndrome. Br Dent J 1989;23:197–200.

41. clifford TJ, Warsi MJ, Burnett ca, Lamey PJ. Burning mouth in Parkinson’s disease sufferers. Gerodontol 1998;15:73–78.